Area of research
Genetics · Cancer Research
Research interest
Research interests include Biology, Medicine, Glioma, Tumor microenvironment, Amyotrophic lateral sclerosis, and CD8.
Abstract PS1-10-28: Phase 1/2a trial of new generation PARP1-selective inhibitor saruparib + next generation selective ER degrader (SERD) camizestrant in patients (pts) with advanced/relapsed ER+/HER2-negative or low (HER2−) breast cancer (PETRA Module 6)
Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate Cancer
ASCERTAIN: An open-label, randomized, phase 1, window-of-opportunity study to investigate the biological effects of AZD5305 and darolutamide alone or in combination in men with prostate cancer eligible for radical prostatectomy.
Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4
Author Correction: Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4
Influenza virus infection causes global RNAPII termination defects
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment
EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer
Most Human Non-GCIMP Glioblastoma Subtypes Evolve from a Common Proneural-like Precursor Glioma
Astrocyte-Specific Expression Patterns Associated with the PDGF-Induced Glioma Microenvironment